Purpose The evidence evaluating the efficacy of i.v. versus oral iron for the treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease (CKD) is reviewed.
On 15 November 2024 at the American Heart Association (AHA) conference in Chicago, Illinois, during a cardiovascular seminar session on the topic of emerging therapies for the treatment of ...
Akebia announced the collaborative trial initiation in September 2024. "We look forward to begin treating CKD anemia patients on dialysis with Vafseo ahead of its anticipated market launch in ...